Press Releases

Varian Holds First Meeting of FlashForward Consortium

Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian (NYSE: VAR) hosted the first meeting of the FlashForward™ Consortium in...

Varian Announces Second Quarter Fiscal Year 2019 Earnings Release Date and Upcoming Investor Event

Varian (NYSE: VAR) today announced its second quarter fiscal year 2019 earnings release date and upcoming investor event. Second Quarter Fiscal Year 2019 Earnings The Company will report results...

Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India

With an estimated 1.8 million new cancer cases a year in India expected by 20251, Tata Trusts and Varian (NYSE: VAR) announced the signing of a framework agreement intended to increase patient...

Varian and Danish Center for Particle Therapy Announce Grand Opening and First Patient Treatments

In a ceremony officiated by the Regional Council of Central Denmark Region, Anders Kühnau, and attended by both the Danish Prime Minister Lars Løkke Rasmussen, and the Chairman of the A.P....

Varian-equipped NSIA-LUTH Cancer Treatment Centre in Nigeria Commissioned

At a ceremony in Idi-Araba, Lagos, Nigeria, Varian (NYSE: VAR) joined H.E. President Muhammadu Buhari, President of the Federal Republic of Nigeria, and other dignitaries to commission the...

Varian Announces South Florida Proton Therapy Institute Joins FlashForward™ Consortium

Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute, a Proton International facility, has joined the FlashForward™ Consortium. Now including 14 members, the consortium...

Varian Eclipse and TrueBeam Named Category Leaders in the 2019 Best in KLAS: Software and Services Report

Varian (NYSE: VAR) today announced its Eclipse™ treatment planning system and TrueBeam® treatment system have been named Category Leaders in the 2019 Best in KLAS: Software and Services Report...

Varian Demonstrating Smarter Cancer Care Solutions at HIMSS19

Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMSS19, booth 6143. Envisioning a world without...

Varian Reports Results for First Quarter of Fiscal Year 2019

First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million...

Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore

Varian (NYSE: VAR) today announced the installation of the gantry for the Varian ProBeam® Compact single-room proton therapy system at the new oncology center at Biopolis, an international...